Skip to content
Screener

Progyny PGNY Operating Cash Flow

Operating Cash Flow at other companies

CVS Health logo
CVS HealthCVS
$6.35B+234%
UnitedHealth Group logo
UnitedHealth GroupUNH
$8.91B+63.3%
Organon logo
OrganonOGN
$225M+200%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
$9.14M+673%
Natera, Inc. logo
Natera, Inc.NTRA
$54.79M+45.8%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$9.31M+69.3%

Other financials

Income statement

See full
Revenue$350.5M+5.3%
Gross profit$89.3M+13.1%
Operating income$40.0M+64.2%
Net income$28.1M+63.9%
EPS (diluted)$0.34+78.9%

Balance sheet

See full
Cash & equivalents$152.6M+15.2%
Total debt$27.0M-5.8%
Total equity$453.3M-12.0%
Total assets$715.8M-5.9%

Cash flow

See full
CapEx$6.2M+18.0%
Free cash flow$44.2M-12.0%

Valuation

See full
Market cap$2.37B+17.5%
Enterprise value$2.24B+17.3%
P/E30.1×-7.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin24.6%+2.2pp
Operating margin8.6%+2.4pp
Net margin6%+1.7pp
FCF margin13.6%-1.7pp

Returns & leverage

See full
Return on equity16.2%+5.3pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.6×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Progyny’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 9:00 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001551306-26-000140
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Accounts payable27,84345,207
Accrued expenses and other current liabilities7,9795,852
Other noncurrent assets and liabilities(3,236)(1,154)
Net cash provided by operating activities96,374105,318
INVESTING ACTIVITIES
Purchase of property and equipment, net(12,566)(8,112)
Purchase of marketable securities(200,088)
Sale of marketable securities112,71293,015

Item 1. Financial Statements (Unaudited)

FAQ

What is Progyny's operating cash flow?
Progyny (PGNY) reported operating cash flow of $50.43M in Q2 2026.
How has Progyny's operating cash flow changed year-over-year?
Progyny's operating cash flow decreased by 9.2% year-over-year, from $55.51M to $50.43M.
What is the long-term trend for Progyny's operating cash flow?
Over 4 years (2021 to 2025), Progyny's operating cash flow has grown at a 68.6% compound annual growth rate (CAGR), from $26.04M to $210.19M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Progyny's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude